All Semliki Forest virus articles
-
NewsA therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
-
NewsRoute of entry for Semliki Forest virus into the brain revealed, yielding brain cancer treatment hope
Researchers have shown that the Semliki Forest virus enters the central nervous system by first entering the cerebrospinal fluid and binding to a specific cell type before penetrating deeper into the brain, potentially tagging the virus as an agent for treating brain cancer.